6461 - 6470 of 8587 Results
Title
Year
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 61
-
OPENTitle: Testing the Protein Propagation Hypothesis of Parkinson DiseaseJournal Name: Journal of Experimental NeurosciencePublisher: SAGE PublicationsVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1179069518786715Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1179069518786715Citation Count: 27
- LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo2021OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 12
- Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial2021OPENTitle: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD TrialJournal Name: Genomics, Proteomics & BioinformaticsPublisher: Oxford University Press (OUP)Vol: 20Issue #: 2Start Page: 274End Page: 287Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009Best OA location URL: https://academic.oup.com/gpb/article-pdf/20/2/274/57583888/gpb_20_2_274.pdfCitation Count: 69
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning2022OPENTitle: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 12Start Page: 2376End Page: 2385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29205Citation Count: 10
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease2023OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 15
-
OPENTitle: PTPA variants and the risk for Parkinson’s disease in diverse ancestry populationsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: e120End Page: e124Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad247Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad247/50913645/awad247.pdfCitation Count: 1
- A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein2018OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
-
OPENTitle: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 8Start Page: 2416End Page: 2425Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8891344Citation Count: 48
- Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease2025OPENTitle: Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43856-025-00817-7Best OA location URL: https://www.nature.com/articles/s43856-025-00817-7.pdfCitation Count: 1